✦ LIBER ✦

Clinical Trials of New and Novel Therapeutic Agents

✍ Scribed by Arthur E. Baue; Rodney M. Durham; John E. Mazuski

Publisher: Springer
Year: 1996
Tongue: English
Weight: 225 KB
Volume: 20
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s002689900078

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines for clinical trials of new th

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

✍ D. E. Goodkin; S. Reingold; W. Sibley; J. Wolinsky; H. McFarland; D. Cookfair; F 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Clinical and statistical issues in thera

Clinical and statistical issues in therapeutic equivalence trials

✍ E. Garbe; J. Röhmel; U. Gundert-Remy 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 762 KB

Absolute proof of efficacy can only be given by placebo controlled trials. It is, however, important to classify a drug within the spectrum of existing therapeutic alternatives and, where effective treatment is available, it may be imperative due to ethical considerations to demonstrate that one dru

Candidate chemoprevention agents in clin

Candidate chemoprevention agents in clinical trials

✍ Waun Ki Hong 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Clinical Trials and New Products

📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

Strategy for design of clinical trials o

Strategy for design of clinical trials of chemopreventive agents

✍ Stimson P. Schantz; Waun Ki Hong; Charles W. Boone; Gary J. Kelioff 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Therapeutic Equivalence – Clinical Issue

Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials

✍ Axel Munk; Hans J. Trampisch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views